NCT05383482 2025-11-17Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1Laekna LimitedPhase 1/2 Completed22 enrolled
NCT07088731 2025-09-22Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting180 enrolled